These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30379550)

  • 1. Polymer-drug conjugates in inflammation treatment.
    Koziolová E; Venclíková K; Etrych T
    Physiol Res; 2018 Oct; 67(Suppl 2):S281-S292. PubMed ID: 30379550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug targeting systems for inflammatory disease: one for all, all for one.
    Crielaard BJ; Lammers T; Schiffelers RM; Storm G
    J Control Release; 2012 Jul; 161(2):225-34. PubMed ID: 22226771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
    Achek A; Yesudhas D; Choi S
    Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis.
    Libánská A; Randárová E; Skoroplyas S; Bartoš M; Luňáčková J; Lager F; Renault G; Scherman D; Etrych T
    J Control Release; 2023 Jan; 353():30-41. PubMed ID: 36403682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation.
    Libánská A; Randárová E; Lager F; Renault G; Scherman D; Etrych T
    Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32722403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing dapsone polymer conjugates for controlled drug delivery.
    Rojo L; Fernandez-Gutierrez M; Deb S; Stevens MM; San Roman J
    Acta Biomater; 2015 Nov; 27():32-41. PubMed ID: 26320539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer Drug Conjugates: Recent Advancements in Various Diseases.
    Singh J; Desai S; Yadav S; Narasimhan B; Kaur H
    Curr Pharm Des; 2016; 22(19):2821-43. PubMed ID: 26898741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapeutic strategies for chronic inflammatory diseases.
    Ferrer E
    Drug News Perspect; 2006; 19(6):353-8. PubMed ID: 16971972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
    Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
    J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.
    Dar MJ; Ali H; Khan A; Khan GM
    J Drug Target; 2017 Aug; 25(7):582-596. PubMed ID: 28277824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art.
    Rahman M; Kumar V; Beg S; Sharma G; Katare OP; Anwar F
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1597-608. PubMed ID: 26758815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
    Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
    Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
    Dahan A; Markovic M; Epstein S; Cohen N; Zimmermann EM; Aponick A; Ben-Shabat S
    Eur J Pharm Sci; 2017 Oct; 108():78-85. PubMed ID: 28627471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
    Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer conjugates. Pharmacokinetic considerations for design and development.
    Duncan R; Spreafico F
    Clin Pharmacokinet; 1994 Oct; 27(4):290-306. PubMed ID: 7834965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.